Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review

E Bosco, L Hsueh, KW McConeghy… - BMC Medical Research …, 2021 - Springer
Background Major adverse cardiovascular events (MACE) are increasingly used as
composite outcomes in randomized controlled trials (RCTs) and observational studies …

An overview and update on the epidemiology of flavonoid intake and cardiovascular disease risk

BH Parmenter, KD Croft, JM Hodgson, F Dalgaard… - Food & function, 2020 - pubs.rsc.org
There is an accumulating body of literature reporting on dietary flavonoid intake and the risk
of cardiovascular disease (CVD) in prospective cohort studies. This makes apparent the …

[HTML][HTML] Potential indirect effects of the COVID-19 pandemic on use of emergency departments for acute life-threatening conditions—United States, January–May …

SJ Lange - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Persons experiencing chest pain, loss of motor function, altered mental status, or other life-
threatening issues should seek immediate emergency care, regardless of the pandemic …

Evaluation of VTE, MACE, and serious infections among patients with RA treated with baricitinib compared to TNFi: a multi-database study of patients in routine care …

CA Salinas, A Louder, J Polinski, TC Zhang… - Rheumatology and …, 2023 - Springer
Introduction The aim of this work is to evaluate baricitinib safety with respect to venous
thromboembolism (VTE), major adverse cardiovascular events (MACE), and serious …

COVID‐19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study

KM D'Silva, A Jorge, A Cohen… - Arthritis & …, 2021 - Wiley Online Library
Objective Patients with systemic autoimmune rheumatic diseases (ARDs) continue to be
concerned about risks of severe coronavirus disease 2019 (COVID‐19) outcomes. This …

The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support

AP Amin, JA Spertus, JP Curtis, N Desai, FA Masoudi… - Circulation, 2020 - Am Heart Assoc
Background: Impella was approved for mechanical circulatory support (MCS) in 2008, but
large-scale, real-world data on its use are lacking. Our objective was to describe trends and …

Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score

RM Kaplan, J Koehler, PD Ziegler, S Sarkar… - Circulation, 2019 - Am Heart Assoc
Background: Studies of patients with cardiovascular implantable electronic devices show a
relationship between atrial fibrillation (AF) duration and stroke risk, although the interaction …

[HTML][HTML] Genomic, pathway network, and immunologic features distinguishing squamous carcinomas

JD Campbell, C Yau, R Bowlby, Y Liu, K Brennan… - Cell reports, 2018 - cell.com
Summary This integrated, multiplatform PanCancer Atlas study co-mapped and identified
distinguishing molecular features of squamous cell carcinomas (SCCs) from five sites …

Long-term exposure to ambient fine particulate matter chemical composition and in-hospital case fatality among patients with stroke in China

M Cai, X Lin, X Wang, S Zhang, C Wang… - The Lancet Regional …, 2023 - thelancet.com
Background There is little evidence on the association between PM 2.5 chemical
components and fatality among hospitalized stroke patients. Methods This study used an …

Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population‐based study

JA Aviña‐Zubieta, F To, K Vostretsova… - Arthritis care & …, 2017 - Wiley Online Library
Objective To estimate the future risk and time trends of newly diagnosed myocardial
infarction (MI), ischemic stroke, or both (cardiovascular disease [CVD]) in individuals with …